Yuichiro Hirata

National Institute of Infectious Diseases

Also affiliated with Kyushu University Hospital, Kitasato University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates”.

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.26.505450

N/A

0DataRank · unranked

8 citations

Shun Iida, Peter Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki‐Horimoto +25 more

Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2

Vaccine(2023)10.1016/j.vaccine.2023.08.054

N/A

0DataRank · unranked

3 citations

Peter Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda +5 more

Correction to “Recombinant Spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2” [Vaccine 22 (41) (2023) 6025–6035]

Vaccine(2025)10.1016/j.vaccine.2025.126880

N/A

0DataRank · unranked

0 citations

Peter Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda +5 more